108 related articles for article (PubMed ID: 12838934)
1. Diabetes technology news. FDA approves CYPHER Stent.
Walczak IM
Diabetes Technol Ther; 2003; 5(3):509-10. PubMed ID: 12838934
[No Abstract] [Full Text] [Related]
2. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography.
Suzuki Y; Ikeno F; Yeung AC
J Invasive Cardiol; 2006 Mar; 18(3):111-4. PubMed ID: 16598109
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stent fracture and acute coronary syndrome.
Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
[TBL] [Abstract][Full Text] [Related]
5. FDA approves Taxus stent; materials managers cheer.
DeJohn P
Hosp Mater Manage; 2004 Apr; 29(4):1, 9. PubMed ID: 15095568
[No Abstract] [Full Text] [Related]
6. "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry.
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J
Z Kardiol; 2004 Apr; 93(4):287-94. PubMed ID: 15085373
[TBL] [Abstract][Full Text] [Related]
7. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
Boam AB
Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451
[TBL] [Abstract][Full Text] [Related]
8. FDA approves health claim for walnuts.
Health News; 2004 Jun; 10(6):6. PubMed ID: 15199896
[No Abstract] [Full Text] [Related]
9. FDA approves health claim labeling for foods containing soy protein.
Stein K
J Am Diet Assoc; 2000 Mar; 100(3):292. PubMed ID: 10719399
[No Abstract] [Full Text] [Related]
10. FDA approves first wearable defibrillator.
FDA Consum; 2002; 36(2):3. PubMed ID: 11989468
[No Abstract] [Full Text] [Related]
11. FDA approves marketing of diclofenac.
Clin Pharm; 1988 Nov; 7(11):785. PubMed ID: 3197378
[No Abstract] [Full Text] [Related]
12. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
[TBL] [Abstract][Full Text] [Related]
13. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
14. FDA approves generic AZT for U.S. market.
O'Rourke M
AIDS Clin Care; 2005 Nov; 17(11):108. PubMed ID: 16323302
[No Abstract] [Full Text] [Related]
15. FDA approves marketing of octreotide.
Clin Pharm; 1989 Jan; 8(1):4. PubMed ID: 2912662
[No Abstract] [Full Text] [Related]
16. FDA approves marketing of cytomegalovirus immune globulin.
Clin Pharm; 1990 Jul; 9(7):493. PubMed ID: 2165448
[No Abstract] [Full Text] [Related]
17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries.
Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977
[TBL] [Abstract][Full Text] [Related]
19. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP;
Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015
[TBL] [Abstract][Full Text] [Related]
20. Let the spin begin. Greater transparency urged for device trials.
Becker C
Mod Healthc; 2005 Mar; 35(11):33. PubMed ID: 15794228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
